お正月まとめセール GLP-1/GIPの週1注射(M)
This medication is a sustained-release GIP/GLP-1 receptor agonist intended for diabetes treatment, but its use for weight loss is not officially approved in Japan. It is administered by subcutaneous injection once a week.
- The description claims that the drug is not officially approved for weight loss in Japan.
- The description mentions potential severe side effects such as gastrointestinal issues, hypoglycemia, and acute pancreatitis.
Specifications
- 用量
- 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 2.5mg+5mg(各半分), 5mg＋7.5mg (各半分), 7.5mg＋10mg(各半分), 10mg＋12.5mg(各半分), 12.5mg＋15mg(各半分)
- プラン
- 12本(3ヶ月), 24本(6ヶ月), 48本(12ヶ月)
Variants (25)
- 2.5mg / 12本(3ヶ月) — 52600.00 JPY — In stock
- 2.5mg / 24本(6ヶ月) — 102800.00 JPY — In stock
- 2.5mg / 48本(12ヶ月) — 205800.00 JPY — In stock
- 5mg / 12本(3ヶ月) — 90400.00 JPY — In stock
- 5mg / 24本(6ヶ月) — 176000.00 JPY — In stock
- 5mg / 48本(12ヶ月) — 349600.00 JPY — In stock
- 7.5mg / 12本(3ヶ月) — 114500.00 JPY — In stock
- 7.5mg / 24本(6ヶ月) — 228000.00 JPY — In stock
- 7.5mg / 48本(12ヶ月) — 463600.00 JPY — In stock
- 10mg / 12本(3ヶ月) — 184400.00 JPY — In stock
- 10mg / 24本(6ヶ月) — 367600.00 JPY — In stock
- 10mg / 48本(12ヶ月) — 637000.00 JPY — In stock
- 12.5mg / 12本(3ヶ月) — 236400.00 JPY — In stock
- 15mg / 12本(3ヶ月) — 274200.00 JPY — In stock
- 2.5mg+5mg(各半分) / 12本(3ヶ月) — 70900.00 JPY — In stock
- 2.5mg+5mg(各半分) / 24本(6ヶ月) — 139400.00 JPY — In stock
- 2.5mg+5mg(各半分) / 48本(12ヶ月) — 280200.00 JPY — In stock
- 5mg＋7.5mg (各半分) / 12本(3ヶ月) — 99950.00 JPY — In stock
- 5mg＋7.5mg (各半分) / 24本(6ヶ月) — 199500.00 JPY — In stock
- 5mg＋7.5mg (各半分) / 48本(12ヶ月) — 401600.00 JPY — In stock
- 7.5mg＋10mg(各半分) / 12本(3ヶ月) — 149450.00 JPY — In stock
- 7.5mg＋10mg(各半分) / 24本(6ヶ月) — 295300.00 JPY — In stock
- 7.5mg＋10mg(各半分) / 48本(12ヶ月) — 542800.00 JPY — In stock
- 10mg＋12.5mg(各半分) / 12本(3ヶ月) — 207900.00 JPY — In stock
- 12.5mg＋15mg(各半分) / 12本(3ヶ月) — 255300.00 JPY — In stock
AI Readiness
Good foundation, but some important product data is still missing.
81%